Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease

Journal: Journal of Clinical Investigation

Published: 2020-01-02

DOI: 10.1172/jci131116

Affiliations: 23

Authors: 54

Go to article
Institutions Share
NIH NIAID Laboratory of Immune System Biology, United States of America (USA) 0.28
NIH NIAID Laboratory of Clinical Immunology and Microbiology (LCIM), United States of America (USA) 0.14
Facultad de Medicina, UdeA, Colombia 0.07
NIH NCI Laboratory of Pathology, United States of America (USA) 0.06
Faculty of Medicine, Erciyes University, Turkey 0.06
NIH National Human Genome Research Institute (NHGRI), United States of America (USA) 0.06
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.06
NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States of America (USA) 0.04
Computational Systems Biochemistry Group, Max Planck Institute of Biochemistry, Germany 0.04
Texas Children's Hospital, BCM, United States of America (USA) 0.04
Department of Physics, BU, United States of America (USA) 0.04
NIH Center for Human Immunology (CHI), United States of America (USA) 0.02
NIH NIAID Biostatistics Research Branch (BRB), United States of America (USA) 0.02
NIH NIAID Laboratory of Infectious Diseases (LID), United States of America (USA) 0.02
NIH Clinical Center, United States of America (USA) 0.02
Shenzhen Children's Hospital, China 0.01
NIH National Cancer Institute (NCI), United States of America (USA) 0.01
Carolinas Medical Center (CMC), Atrium Health, United States of America (USA) 0.01
Levine Children's Hospital, Atrium Health, United States of America (USA) 0.01
Mayo Clinic Department of Laboratory Medicine and Pathology (DLMP), United States of America (USA) 0.01
Mayo Clinic College of Medicine and Science, United States of America (USA) 0.01
NIH National Institute of Neurological Disorders and Stroke (NINDS), United States of America (USA) 0.01

Return